Wolf popper llp announces investigation on behalf of applied therapeutics, inc. investors

New york, dec. 06, 2024 (globe newswire) -- wolf popper llp is investigating potential claims on behalf of purchasers of applied therapeutics, inc. (“applied therapeutics”) common stock (nasdaq: aplt). applied therapeutics is a clinical-stage biopharmaceutical company.
APLT Ratings Summary
APLT Quant Ranking